Saturday, February 7, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Breaking News

UBS Analyst Maintains Neutral Rating on ZipRecruiter Lowers Price Target to 13

Elaine Mendonca by Elaine Mendonca
March 15, 2024
in Breaking News
0
Finance_ People trading stocks
0
SHARES
1
VIEWS
Share on FacebookShare on Twitter

UBS analyst Kunal Madhukar has decided to keep a Neutral rating on ZipRecruiter (NYSE: ZIP) as of March 15, 2024. However, he has revised the price target downward from $14 to $13. This change in target price is based on UBS’s evaluation of ZipRecruiter’s current performance and future prospects in the market.

ZIP Stock Shows Positive Price Momentum on March 15, 2024: Potential for Growth Ahead

On March 15, 2024, ZIP stock experienced a positive price momentum as it traded near the bottom of its 52-week range and below its 200-day simple moving average. Despite these factors, the stock saw an increase in its price, gaining $0.53 since the market last closed, representing a 4.41% rise from its previous closing price of $12.55.

In pre-market trading, ZIP stock continued to show signs of growth as it rose an additional $0.22. This positive price movement indicates that investors may be feeling optimistic about the company’s future prospects.

Investors should consider other factors such as the company’s financial health, market trends, and industry outlook before making any investment decisions.

Overall, the performance of ZIP stock on March 15, 2024, suggests that there is potential for growth in the company. However, investors should conduct thorough research and analysis before making any investment decisions to ensure they are making informed choices.

ZIP Stock Performance Update: Decline in Revenue, Net Income, and EPS, But Stability Since Last Quarter

On March 15, 2024, ZIP stock experienced a mixed performance based on the latest financial data provided by CNN Money. The company reported a total revenue of $645.72 million for the past year, which represents a 28.62% decrease compared to the previous year. However, the total revenue remained flat since the last quarter, indicating some stability in the company’s revenue stream.

In terms of net income, ZIP reported a net income of $49.10 million for the past year, which is a 20.16% decrease from the previous year. Similar to the total revenue, the net income also held flat since the last quarter, suggesting that the company was able to maintain its profitability despite the decrease in revenue.

Earnings per share (EPS) for ZIP stock were reported at $0.46 for the past year, representing an 8.35% decrease from the previous year. The EPS also saw a significant decline of 76.25% since the last quarter, indicating a sharp drop in the company’s earnings on a per-share basis.

Overall, ZIP stock’s performance on March 15, 2024, reflected a mixed picture with a decline in total revenue, net income, and earnings per share compared to the previous year. However, the company was able to maintain stability in its financial performance since the last quarter, which could be seen as a positive sign for investors.

Tags: ZIP
Elaine Mendonca

Elaine Mendonca

Related Posts

NFT projects
Breaking News

The Impact of TikToks Fate on USChina Relations and American Tech Giants

March 16, 2024
Businesses finance
Breaking News

Blackstone Strategic Credit 2027 Term Fund BGB Announces Monthly Dividend of 93 Cents per Share

March 15, 2024
Healthcare-sector
Breaking News

Analyzing Short Interest in Molina Healthcare Inc MOH

March 15, 2024
Next Post

Seanergy Maritime Holdings Corp Reports Surprising Increase in Q4 Earnings

Beauty Industry Markets and money

Analyst Reaffirms Positive Outlook on Beauty Health SKIN with Buy Rating and 5 Price Target

Finance_ Investing in stocks

Analyst Matt Summerville Bullish on Alta Equipment Group with 22 Price Target

Recommended

Gold Stock

Gold Nears Historic Peak as Market Anticipation Builds

2 months ago
Dentist

Advancements in Oral Healthcare: The Business Impact of Highly Trained Surgeons

2 years ago
Archer Aviation Stock

Archer Aviation Strengthens Market Position Through Strategic Patent Acquisition

4 months ago
SNDR stock news

Yousif Capital Management LLC Reduces Stake in Steven Madden, Ltd.: Implications for the Company’s Future Performance

3 years ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Broadcom Coca-Cola Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Newmont Mining NIO Novo Nordisk Nvidia Ocugen Opendoor Oracle Palantir PayPal Plug Power QuantumScape Robinhood Rocket Lab USA Strategy Super Micro Computer Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics
No Result
View All Result

Highlights

Amazon’s $200 Billion Penalty, The Bad News Rally, and A Cloud Divorce

Graftech Shares Plunge on Bleak Quarterly Results

Potbelly Accelerates Northeast Growth with New Jersey Franchise Push

Conduent Faces Mounting Fallout from Major Data Breach Ahead of Earnings

Blue Ridge Bankshares Emerges from Regulatory Challenges with Return to Profitability

Navigating the Interest Rate Tightrope: Bank7’s Path Forward

Trending

Design Therapeutics Stock
Analysis

Design Therapeutics Approaches Key Clinical Milestones with Ample Funding

by Rodolfo Hanigan
February 7, 2026
0

Investor attention is turning to the upcoming catalysts for Design Therapeutics, a biotechnology firm advancing its GeneTAC...

Vigil Neuroscience Stock

Sanofi Completes Vigil Neuroscience Acquisition, Eyes Alzheimer’s Therapy

February 7, 2026
Repay Holdings Stock

Repay Holdings: Annual Report to Test Strategic Refinancing Success

February 7, 2026
Amazon’s $200 Billion Penalty, The Bad News Rally, and A Cloud Divorce

Amazon’s $200 Billion Penalty, The Bad News Rally, and A Cloud Divorce

February 7, 2026
Graftech Stock

Graftech Shares Plunge on Bleak Quarterly Results

February 7, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Design Therapeutics Approaches Key Clinical Milestones with Ample Funding
  • Sanofi Completes Vigil Neuroscience Acquisition, Eyes Alzheimer’s Therapy
  • Repay Holdings: Annual Report to Test Strategic Refinancing Success

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com